Orphazyme no longer expects EMA decision this year
![Photo: Orphazyme/PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13339864.ece/ALTERNATES/schema-16_9/doc7htzgrd4i8814ppo93xq.jpg)
Biotech company Orphazyme, which is based in Copenhagen, Denmark, must arm itself with more patience.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Orphazyme expects to lay off 100 employees this year
For subscribers
Orphazyme to discuss NPC rejection with FDA in mid-October
For subscribers
Orphazyme may face class action suit from US investors
For subscribers